Sep 26, 2023 / 01:45PM GMT
Unidentified Participant
Biotech Equity Research Team, I'm very pleased to introduce from Avidity Biosciences, we have Sarah Boyce, Chief Executive Officer and President, and Mike Flanagan, Chief Science and Technology Officer. So why don't we set the stage first with a quick snapshot of the platform and the programs, and then we're going to go on a little logical thought exercise that I think, I hope, is going to be like illustrative, especially as we think about some of the conclusions and applying them to the myotonic dystrophy program.
Sarah Boyce - Avidity Biosciences, Inc. - President & CEO
Awesome. Thanks, Josh. And thank you so much for inviting us. It's really a pleasure to be here.
Unidentified Participant
Super. All right. So a quick snapshot of the platform and the LEAD programs.
Sarah Boyce - Avidity Biosciences, Inc. - President & CEO
Yeah. Absolutely. So Avidity, we are an RNA delivery company. The company was founded with the goal of tackling what's been one of the
Avidity Biosciences Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Sep 26, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers